2010 Global
Moot Corp® Competition
The Super Bowl of World Business Plan Competition
May 5 - 8, 2010
The University of Texas at Austin
Start-Up
Advice from Moot Corp Alumni
Recently, a panel of former Texas Moot Corp participants
and entrepreneurs gathered to share insights on
topics such as raising venture capital, hiring the right team and how to learn
from mistakes along the way. In the video, they share some excellent advice on
the start-up process.
View the video.
Novophage Therapeutics Wins 2009 Global Moot Corp Competition
A
company hoping to significantly slow the onset of antibiotic resistance claimed
the grand prize at the 26th annual Global Moot Corp Competition held at the
University of Texas at Austin on Saturday, May 9. Novophage Therapeutics
from Boston University and MIT beat out 39 teams from top MBA programs around
the world to claim the Global Champion prize.
Novophage Therapeutics will introduce a new biological therapy that slows
the onset of antibiotic resistance and increases the efficacy of current
antibiotics. The company plans to offer efficacious treatments for highly
antibiotic-resistant bacterial infections, allowing infectious disease doctors
to better manage the fight against multidrug-resistant strains through
co-administration of engineered bacteriophages with current clinical standards
of care. Team members include Timothy Lu, Tanguy Chau, Michael Koeris and Ann
DeWitt.
Schedule of Events
Rules and GuidelinesAbout Moot Corp History
of Competition
Awards
Texas Moot Corp Competition
|
|
|
|
|
|||||||||||||||
|
||||||||||||||||














